Dai, Hanying
He, Hanqing
Zhang, Yanyang
Xu, Juan
Che, Jie
Zhu, Yao
Fu, Tao
Chen, Chuanwei
Zhou, Qian
Chen, Bohan
Gao, Yuan
Qin, Aiping
Zhang, Maojun
Shao, Zhujun
Funding for this research was provided by:
the National Science Foundation of China (No. 81973106)
Sanofi (No. PER00082)
Operation of Public Health Emergency Response Mechanisms - Infectious Disease Control (102393220020020000029)
Enhancement of Infectious Disease Surveillance and Control Technological Capabilities (102393240020020000003)
Article History
Received: 17 June 2024
Accepted: 22 November 2024
First Online: 9 December 2024
Declarations
:
: This study has been approved by the China CDC’s Institutional Review Board (no. ICDC-202110). All investigators received confidentiality and ethics training to mitigate the risk of potential confidentiality loss. Interviews, consent forms, and survey data were securely managed. Participation was voluntary, with written informed consent for data collection.
: The authors declare no competing interests.